 | |
| dsm-firmenich | |
| |
| ISIN | CH1216478797 |
| Industry | Chemicals |
| Predecessors | |
| Founded | 9 May 2023; 2 years ago (2023-05-09) |
| Headquarters |
|
| Products | Nutritional ingredients, specialty food ingredients, UV filters,fragrances,flavorings,enzymes,human milk oligosaccharide |
| Revenue | €12.799 billion (2024) |
| €2.118 billion (2024) | |
| Total assets | €33.7 billion (2024) |
| Total equity | €22.5 billion (2024) |
Number of employees | ~ 30,000 |
| Website | dsm-firmenich |
| Footnotes / references [1] | |
DSM-Firmenich AG is aSwiss-Dutch chemical company. It was formed on 9 May 2023[2] through the merger ofRoyal DSM and the Swiss companyFirmenich. The company is listed onEuronext Amsterdam and is a constituent of theAEX index.
The announcement of the merger betweenDSM andFirmenich was first made in 2022[3] with a goal of establishing a leading nutrition and personal care ingredients company. The merger was considered by both organizations to be a "merger of equals"[4]. The merger was completed on 9 May 2023[2].
On 30 May 2024, a new headquarters in Maastricht was officially opened byQueen Máxima of the Netherlands.[5]
On 11 February 2025, Novonesis reached an agreement with the company to acquire its shares in the Feed Enzyme Alliance for €1.5 billion.[6] The agreement would dissolve the Alliance and have Novonesis take over all sales and distribution activities.
The company has over 300 locations in more than sixty countries.[1]
Corporate activities are divided into four business units[1]: Perfumery & Beauty; Health, Nutrition, and Care; Taste, Texture & Health; and Animal Nutrition and Health.
